Peter Kies - 03 Jun 2021 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
CFO
Signature
Peter Kies
Issuer symbol
INO
Transactions as of
03 Jun 2021
Net transactions value
-$80,300
Form type
4
Filing time
04 Jun 2021, 16:08:38 UTC
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Sale $80,300 -10,000 -6.2% $8.03* 150,788 03 Jun 2021 Direct F1, F2
holding INO Common Stock 4,500 03 Jun 2021 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 These transactions were executed in multiple trades at prices ranging from $8.00 to $8.09, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.